ACVR2B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.724010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.934800E-01
Normal-vs-Stage2
5.122500E-02
Normal-vs-Stage3
6.136000E-02
Normal-vs-Stage4
2.259800E-01
Stage1-vs-Stage2
1.166560E-01
Stage1-vs-Stage3
2.192400E-02
Stage1-vs-Stage4
4.261800E-01
Stage2-vs-Stage3
1.62458935193399E-12
Stage2-vs-Stage4
9.853800E-01
Stage3-vs-Stage4
1.632000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.019200E-01
Normal-vs-AfricanAmerican
6.481700E-02
Normal-vs-Asian
7.506200E-02
Caucasian-vs-AfricanAmerican
8.906600E-01
Caucasian-vs-Asian
4.976600E-01
AfricanAmerican-vs-Asian
5.847000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.549810E-01
Normal-vs-Female
2.088400E-01
Male-vs-Female
9.502400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.480600E-01
Normal-vs-Age(41-60Yrs)
1.989560E-01
Normal-vs-Age(61-80Yrs)
1.896950E-01
Normal-vs-Age(81-100Yrs)
9.538400E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.392600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.173200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.689810E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.608560E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.238300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.176400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.204100E-02
Normal-vs-Daily Drinker
1.128780E-01
Normal-vs-Weekly Drinker
7.575200E-03
Normal-vs-Occasional Drinker
7.026000E-01
Normal-vs-Social Drinker
2.571400E-01
Non Drinker-vs-Daily Drinker
6.510200E-01
Non Drinker-vs-Weekly Drinker
9.176800E-01
Non Drinker-vs-Occasional Drinker
1.347000E-01
Non Drinker-vs-Social Drinker
1.697770E-01
Daily Drinker-vs-Weekly Drinker
6.786200E-01
Daily Drinker-vs-Occasional Drinker
2.260800E-01
Daily Drinker-vs-Social Drinker
3.504800E-01
Weekly Drinker-vs-Occasional Drinker
1.339380E-01
Weekly Drinker-vs-Social Drinker
1.504160E-01
Occasional Drinker-vs-Social Drinker
5.738000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.493600E-01
Normal-vs-Grade 2
2.345400E-01
Normal-vs-Grade 3
1.101970E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.182000E-02
Grade 1-vs-Grade 3
3.165800E-01
Grade 1-vs-Grade 4
3.493600E-01
Grade 2-vs-Grade 3
5.987800E-02
Grade 2-vs-Grade 4
2.345400E-01
Grade 3-vs-Grade 4
1.101970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.137600E-03
Normal-vs-NonDiabetic
2.767200E-01
Diabetic-vs-NonDiabetic
1.577900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.290300E-02
Normal-vs-NoPancreatitis
2.022400E-01
Pancreatitis-vs-NoPancreatitis
2.458200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.527400E-01
Normal-vs-N1
5.590300E-02
N0-vs-N1
2.818800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.317440E-01
Normal-vs-TP53-NonMutant
5.202800E-01
TP53-Mutant-vs-TP53-NonMutant
2.358000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
